Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custirsen + NHT in Localized Prostate Cancer
NCT00138918Phase 2Completed
- Sponsor
- University of British Columbia
- Start
- Jun 2005
- Primary completion
- May 2008
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 2 trial of custirsen in prostate cancer (PCa), sponsored by University of British Columbia. Started Jun 2005; status: completed.
02
Drugs
custirsen
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00138918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138918.